+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
FEMALE
ID05953402

Observational Study of Ozanimod Safety During Pregnancy in Women With Ulcerative Colitis and Their Babies

Led by Bristol-Myers Squibb · Updated on 2026-06-15

1182

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This observational study evaluates the relationship between exposure to ozanimod during pregnancy and outcomes for mothers, fetuses, and infants who have ulcerative colitis UC. It compares pregnant women with UC exposed to ozanimod, conventional therapies, or advanced therapies during pregnancy to assess safety and health outcomes of both mother and child. Participants are grouped based on their exposure during pregnancy those receiving ozanimod, those using conventional therapies like aminosalicylates or thiopurines but not ozanimod or advanced therapies, and those treated with advanced therapies such as biologics or small molecules but not ozanimod or other S1P therapies. The study collects data on the occurrence of major and minor congenital malformations, pregnancy complications, and infant health outcomes up to 12 months after birth. Participants will be observed throughout pregnancy and the first year of the infants life, with outcomes assessed including rates of congenital malformations, pre-eclampsia, spontaneous abortion, stillbirth, preterm birth, growth deficiencies, developmental issues, infant infections, and mortality. The primary outcome is the event rate of major congenital malformations up to 12 months. Data collection involves monitoring maternal and infant health events over these time frames to understand the potential impact of ozanimod exposure.

CONDITIONS

Brief Title

A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

Research Team

B

BMS Study Connect Contact Center www.BMSStudyConnect.com

F

First line of the email MUST contain the NCT# and Site #.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here